Cargando…
Multi-biomarker is an early-stage predictor for progression of Coronavirus disease 2019 (COVID-19) infection
Coronavirus disease 2019 (COVID-19) has spread widely in the communities in many countries. Although most of the mild patients could be cured by their body's ability to self-heal, many patients quickly progressed to severe disease and had to undergo treatment in the intensive care unit (ICU). T...
Autores principales: | Zhou, Zheng, Li, Ying, Ma, Yuanhui, Zhang, Heng, Deng, Yunfeng, Zhu, Zuobin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241766/ https://www.ncbi.nlm.nih.gov/pubmed/34220307 http://dx.doi.org/10.7150/ijms.58742 |
Ejemplares similares
-
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort
por: Cheng, B., et al.
Publicado: (2020) -
Malnutrition Contributes to Low Lymphocyte Count in Early-Stage Coronavirus Disease-2019
por: Zhang, Kai, et al.
Publicado: (2022) -
Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients
por: Yang, Zongguo, et al.
Publicado: (2020) -
Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019
por: Luo, Ying, et al.
Publicado: (2020) -
Computed tomography manifestations in super early stage 2019 novel coronavirus pneumonia
por: Hu, Shan, et al.
Publicado: (2020)